Dr. Reddy`s Laboratories's current cash is $11B.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (June 2026), RDY shows a current cash of $11B. That compares with $9B in the prior-year period — up 24.4% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, RDY's current cash is now $11B (was $9B) — a 24.4% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Dr. Reddy`s Laboratories is outperforming or lagging.
Tracking RDY's current cash over time shows whether Dr. Reddy`s Laboratories is scaling, shrinking, or reshaping that part of the business. The current reading is $11B That compares with $9B in the prior-year period — up 24.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this current cash page, Stockcircle has Dr. Reddy`s Laboratories's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $11B) with ownership activity and broader fundamentals.
Dr. Reddy`s Laboratories's current cash is $11B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.